NPM1-mutated acute myeloid leukemia (AML) represents about one-third of all adult AML [1] and, due its unique clinicopathological and genetic features [2], is recognized as a leukemia entity of the World Health Organization (WHO) Classification of myeloid neoplasms. This evidence concerns the gene NPM1 and acute myeloid leukemia.